Douglass Winthrop Advisors LLC Has $1.94 Million Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Douglass Winthrop Advisors LLC trimmed its stake in Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 1.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,293 shares of the medical instruments supplier’s stock after selling 20 shares during the period. Douglass Winthrop Advisors LLC’s holdings in Mettler-Toledo International were worth $1,939,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Advisors Asset Management Inc. lifted its holdings in Mettler-Toledo International by 17.1% during the 1st quarter. Advisors Asset Management Inc. now owns 1,366 shares of the medical instruments supplier’s stock valued at $1,819,000 after purchasing an additional 199 shares during the last quarter. BOKF NA raised its stake in shares of Mettler-Toledo International by 11.7% in the first quarter. BOKF NA now owns 1,155 shares of the medical instruments supplier’s stock valued at $1,549,000 after acquiring an additional 121 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Mettler-Toledo International by 88.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after acquiring an additional 57,509 shares in the last quarter. B. Riley Wealth Advisors Inc. bought a new stake in Mettler-Toledo International during the 1st quarter worth approximately $317,000. Finally, Meiji Yasuda Life Insurance Co acquired a new stake in Mettler-Toledo International during the 1st quarter valued at $666,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,217.97 on Monday. Mettler-Toledo International Inc. has a fifty-two week low of $1,059.08 and a fifty-two week high of $1,546.93. The firm has a market capitalization of $25.70 billion, a P/E ratio of 32.84, a P/E/G ratio of 4.02 and a beta of 1.16. The company’s 50 day simple moving average is $1,361.85 and its 200 day simple moving average is $1,399.98.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Sell-side analysts expect that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.94% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research firms have commented on MTD. JPMorgan Chase & Co. boosted their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company lowered their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Finally, Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $1,338.75.

View Our Latest Report on MTD

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

See Also

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.